4 October 2023 - The Department of Health and Social Care has asked NICE to produce guidance on using ravulizumab ...
6 October 2023 - NICE recently completed a review of its methods for health technology assessment, involving a 2 stage ...
4 October 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
6 October 2023 - This study aimed to estimate the incremental health benefits of pharmaceutical innovations approved between 2011 and 2021 ...
4 October 2023 - NICE has recommended evidence based recommendations on the use of bimekizumab (Bimzelx) for the treatment of ...
4 October 2023 - NICE has published evidence-based recommendations on the use of pegunigalsidase alfa (Elfabrio) for the treatment of ...
3 October 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
26 September 2023 - NICE has today published draft guidance for public consultation that does not recommend trastuzumab deruxtecan for ...
22 September 2023 - Eli Lilly announced today that NICE has recommended mirikizumab for the treatment of adults with moderately ...
20 September 2023 - NICE has published evidence-based recommendations on the use of pembrolizumab (Keytruda) for the adults with previously ...
14 September 2023 - The first treatment to be recommended by NICE for treating acute migraine will soon be available on ...
11 September 2023 - NICE has issued final draft guidance recommending UCB's Bimzelx (bimekizumab), with the inflammatory disease drug now ...
12 September 2023 - In 2022, NICE introduced the first phase of a new proportionate approach to technology appraisals. ...
8 September 2023 - Around 180,000 people with difficult to manage type 2 diabetes could benefit from a new treatment ...
6 September 2023 - NICE has published final evidence-based recommendations on the use of mavacamten (Camzyos) for the treatment of ...